FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to synthetic immunomodulators based on chloraromatic urea derivative. Compound of meta-chlorobenzhydrylurea is used as an immunomodulator in chronic alcoholism.
EFFECT: use of said compound enables modulating the functional activity of the immune system and cell elements thereof in chronic alcoholism.
1 cl, 2 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATOR | 2019 |
|
RU2702114C1 |
| METHOD FOR REDUCING ALCOHOLIC MOTIVATION IN MICE | 2020 |
|
RU2744411C1 |
| IMMUNOMODULATOR | 2020 |
|
RU2747986C1 |
| IMMUNOSTIMULATING AGENT | 1993 |
|
RU2098110C1 |
| AGENT DECREASING ALCOHOLIC MOTIVATION | 1999 |
|
RU2155034C1 |
| AGENT WITH COMBINED NORMALIZING EFFECT ON IMMUNE AND DIGESTIVE BODY SYSTEMS | 2015 |
|
RU2611377C2 |
| IMMUNODEPRESSANT | 2016 |
|
RU2637642C1 |
| METHOD FOR BRAIN CELL REGENERATION WITH RECOVERY OF ITS FUNCTIONS | 2023 |
|
RU2816789C1 |
| IMMUNOMODULATOR METABOLITE DETOXICANT - ADAPTOGEN RADIOPROTECTOR | 2000 |
|
RU2194502C2 |
| METHOD FOR CREATING ANTI-INFECTIOUS IMMUNOLOGICAL PROTECTION AGAINST SALMONELLA TYPHIMURIUM AND LISTERIA MONOCYTOGENES USING TRANSGENESIS OF T-LYMPHOCYTES | 2018 |
|
RU2706554C1 |
Authors
Dates
2019-06-11—Published
2018-04-06—Filed